2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1568489003 MD
Verify on CMS →

Thomas Moraghan, MD

Endocrinology, Diabetes & Metabolism Physician in Brainerd, Minnesota.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
450
Medicare Part D claims · 78 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
49%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

Thomas Moraghan, MD filed 450 Medicare Part D claims in 2023 as an Endocrinology, Diabetes & Metabolism Physician in Brainerd, Minnesota, prescribing 49% generic.

450
Part D claims, 2023
49%
generic prescribing
Likely
board-certified (heuristic)
≥62nd
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

CMS NPPES provider registry desk

NPI 1568489003 · Endocrinology, Diabetes & Metabolism Physician

NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1568489003
  • ENUM-LEGACY 2006
  • TAX-MID 8K Endocrinology, Diabetes
  • RX-LIGHT 450
  • BOOK-THIN 141 in Minnesota
  • PHOTO-ENUM Stuart Ley · 2006

Thomas Moraghan, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

450 ≥ 62nd percentile 62% of 1,370,886 prescribers are in lower value bands

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic, not verified)

Thomas Moraghan, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Thomas Moraghan, MD?

Quality data not reported

NPI registry status

Active

Issued 07/17/2006

NPI 1568489003

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,871 US NPIs in this specialty

Medicare Part D claims

450 83% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Minnesota

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Minnesota providers

Minnesota providers
Behavior Technician11.7%Clinical Social Worker4.7%Physical Therapist4.1%Pharmacist3.7%Student in an Organized Heal…3.4%Mental Health Counselor3.1%Endocrinology, Diabetes & Me…0.1%
Largest specialties in Minnesota (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

2024 S 6TH ST
Brainerd, MN 56401

Provider Details

NPI 1568489003
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Male
NPI Issued 07/17/2006

Hospital and facility affiliations

Facilities where Thomas Moraghan, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Lakewood Health System
Staples, MN
Critical Access Hospitals
CMS CCN: 241329

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Above average

Thomas Moraghan, MD - brand share 41.0%
Endocrinology, Diabetes & Metabolism Physician average

41% brand-name claims vs 49% generic, on 450 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

450
Total Claims
$167K
Total Drug Cost
78
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
853
Total Day Supply
24,667
Brand vs Generic
41% brand / 49% generic
Brand Drug Cost
$139K
Generic Drug Cost
$5K

Patient Demographics

Average Patient Age
68.5 years
Avg HCC Risk Score
1.17
Gender Split
78% female / 22% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Thomas Moraghan, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
96
Methimazole
53
Alendronate Sodium
42
Hydrocortisone
18
Humalog Kwikpen U-100
Insulin Lispro
16
Jardiance
Empagliflozin
13
Fludrocortisone Acetate
12
Metformin Hcl Er
Metformin Hcl
12
Synthroid
Levothyroxine Sodium
12
Calcitriol
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How Thomas Moraghan, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

Thomas Moraghan, MD's 450 claims are below the specialty average of 2,639.

Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Moraghan, both outside Minnesota so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2006)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Minnesota

Other clinicians with the same primary specialty enrolled in Minnesota, drawn from the same CMS NPPES roster as Moraghan.

One of 141 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Minnesota, 5 are shown here.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Thomas Moraghan, MD's specialty?
Thomas Moraghan, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Brainerd, Minnesota. Credentials: MD.
How much does Thomas Moraghan, MD prescribe under Medicare Part D?
In 2023, Thomas Moraghan, MD wrote 450 Medicare Part D claims totaling $167K in drug costs for 78 beneficiaries.
Where is Thomas Moraghan, MD located?
Thomas Moraghan, MD is located at 2024 S 6TH ST, Brainerd, MN, 56401. Phone: (218) 828-7100.
What is Thomas Moraghan, MD's NPI number?
Thomas Moraghan, MD's National Provider Identifier (NPI) is 1568489003, issued on 07/17/2006.
Does Thomas Moraghan, MD prescribe more brand-name or generic drugs?
Thomas Moraghan, MD's prescribing is 41% brand-name and 49% generic drugs by claim count, with $139K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Thomas Moraghan, MD prescribe most often?
Based on 2023 Medicare Part D data, Thomas Moraghan, MD's most frequently prescribed drugs include Levothyroxine Sodium, Methimazole, Alendronate Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Thomas Moraghan, MD accept Medicare?
Thomas Moraghan, MD appears in CMS Medicare data with 450 Part D claims and 78 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Thomas Moraghan, MD's credentials?
Thomas Moraghan, MD's NPI is 1568489003 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.